FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Biogen Shares Rise Following Analyst Upgrade and Drug Acquisition

      Biogen Inc. experienced a 3.6% increase in its stock price during the afternoon trading session. This rise follows an upgrade from Wells Fargo, which has positively influenced investor sentiment towards the biotech company.

      In addition to the analyst upgrade, Biogen announced that it has secured exclusive worldwide rights for the drug candidate felzartamab. This acquisition is expected to enhance the company's portfolio and potentially contribute to future growth.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud